Clinical Trials in Denver

Showing 11161-11180 of 15,604 trials

Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)

NCT00200967

The purpose of this trial is to determine whether regularly scheduled use of an inhaled long-acting beta agonist (salmeterol) in the setting of concomitant use of inhaled corticosteroids (beclomethasone hydroflouroalkane (HFA) inhaler) will have a detrimental effect on asthma control in people who bear the B16-Arg/Arg genotype of the beta-2 adrenergic receptor gene, as compared to people with asthma of similar severity who bear the B16-Gly/Gly genotype.

Asthma

Milton S. Hershey Medical Center87 participantsStarted Dec 2004

San Diego, California, United States • San Francisco, California, United States • Denver, Colorado, United States +4 more locations

COMPLETEDNA< 1 mile

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

NCT02649478

A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared with Advair Diskus® 100/50 in Subjects with Asthma

Asthma

Roxane Laboratories1,430 participantsStarted Aug 2014

Glendale, Arizona, United States • Phoenix, Arizona, United States • Surprise, Arizona, United States +97 more locations

Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

Find Trials by Condition in Denver

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes

Normal Values of Oxidative Stress, Taurine, and Related Markers

An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Multi-site Validation and Application of a Consensus DSC-MRI Protocol

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age

TR(ACE) Assay Clinical Specimen Study